Luis Antonio DíazEduardo Fuentes–LópezGustavo AyaresFrancisco IdalsoagaJorge ArnoldMaría Ayala-ValverdeDiego PérezJaime GómezRodrigo EscarateAlejandro Villalón2026-03-222026-03-22202310.1016/j.jhepr.2023.100727https://doi.org/10.1016/j.jhepr.2023.100727https://andeanlibrary.org/handle/123456789/43811Citaciones: 30enRenal replacement therapyMedicineIntensive care medicineAlcoholInternal medicineMELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitisarticle